# Intended Use — MICROBOTICA ## Platform Positioning Statement MICROBOTICA (MICROROBOTics Iterative simulation for Clinical Adoption) is open-source research software. It is not a medical device as defined by EU MDR (EU 2017/745), Article 2(1). It has no medical purpose. It is not intended for clinical use, clinical decision-making, or patient diagnosis. It has not been CE-marked, cleared, or approved by any regulatory body. MICROBOTICA is a research simulator for microrobot-assisted drug delivery simulations. It provides: - A desktop application for interactive visualisation of microrobotics simulations - A Python scripting console for parameter manipulation and analysis - OpenUSD-based scene management with three-layer composition - Pluggable compute and render backends ## Layered Responsibility Model | Layer | Project | Responsibility | |-------|---------|---------------| | 1 | MADDENING | Physics framework — produces simulation data | | 2 | MIME | Microrobotics engine — domain-specific physics | | 3 | **MICROBOTICA** | Simulator UI — visualisation, scripting, scene management | | 4 | Commercial Product | CE-marked SaMD — bears all EU MDR obligations | MICROBOTICA does not produce physics data. It receives, displays, and allows interaction with physics data produced by upstream layers. MICROBOTICA's correctness obligation is **faithful rendering**: data received from the physics backend must be displayed without corruption or silent modification. ## Commercial Boundary Statement When a downstream commercial manufacturer incorporates MICROBOTICA into a regulated medical device, MICROBOTICA is classified as SOUP (Software of Unknown Provenance) under IEC 62304. The device manufacturer is solely responsible for: - Classifying MICROBOTICA under the applicable software safety class - Performing all required verification and validation - Assessing MICROBOTICA's known anomalies for safety relevance in their context of use - Implementing any required risk controls or mitigations - Maintaining regulatory submissions and post-market surveillance ## Cybersecurity Boundary Statement MICROBOTICA does not implement security controls for clinical deployment. It does not provide: - User authentication or authorisation - Encrypted data storage or transmission - Audit trail integrity protection - Network security controls When deployed in a clinical context, the downstream manufacturer must implement all required cybersecurity controls per MDCG 2019-16. ## AGPL Licence Statement MICROBOTICA is licensed under AGPL-3.0-or-later. Downstream commercial manufacturers must ensure their use complies with AGPL terms. The AGPL licence does not constitute a medical device licence or regulatory approval.